Neovasc Inc
TSX:NVCN

Watchlist Manager
Neovasc Inc Logo
Neovasc Inc
TSX:NVCN
Watchlist
Price: 40.15 CAD Market Closed
Market Cap: 110.8m CAD

Neovasc Inc
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Neovasc Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Neovasc Inc
TSX:NVCN
Net Income (Common)
-$41.2m
CAGR 3-Years
-5%
CAGR 5-Years
-12%
CAGR 10-Years
-64%
Titan Medical Inc
TSX:TMD
Net Income (Common)
-$5m
CAGR 3-Years
49%
CAGR 5-Years
39%
CAGR 10-Years
10%
Profound Medical Corp
TSX:PRN
Net Income (Common)
-$39.3m
CAGR 3-Years
-10%
CAGR 5-Years
-17%
CAGR 10-Years
-12%
Theralase Technologies Inc
XTSX:TLT
Net Income (Common)
-CA$4.4m
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
2%
MedMira Inc
XTSX:MIR
Net Income (Common)
-CA$4.5m
CAGR 3-Years
-35%
CAGR 5-Years
-17%
CAGR 10-Years
-3%
O
Ondine Biomedical Inc
LSE:OBI
Net Income (Common)
-CA$19.1m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Neovasc Inc
Glance View

Market Cap
110.5m CAD
Industry
Health Care

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures and markets products for the cardiovascular marketplace. The firm's products include the Neovasc ReducerTM (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle and the TiaraTM (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.

NVCN Intrinsic Value
Not Available

See Also

What is Neovasc Inc's Net Income (Common)?
Net Income (Common)
-41.2m USD

Based on the financial report for Dec 31, 2022, Neovasc Inc's Net Income (Common) amounts to -41.2m USD.

What is Neovasc Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-64%

Over the last year, the Net Income (Common) growth was -66%. The average annual Net Income (Common) growth rates for Neovasc Inc have been -5% over the past three years , -12% over the past five years , and -64% over the past ten years .

Back to Top